About Event

Cancelled: Why Attend the Neuromodulation Summit?

Your one-stop shop to capturing industry’s most cutting-edge insights into optimizing trial design, navigating the regulatory landscape, and addressing reimbursement strategy to move the needle in device approvals and adoption.

As the global neuromodulation device market is currently estimated at $10 million and is expected to register a CAGR of 12.4% from 2024 to 2034, the Neuromodulation Summit is a must-attend meeting to capture all the latest strategies and insights you need to contribute to the paradigm shift.

Diving into the advances in closed-loop systems, biopotential sensing, bio-ultrasonic therapy, and injectable devices, this is your exclusive learning and networking opportunity to advance your devices’ clinical developments and routes towards global regulatory approval and patient adoption.

Don’t miss out on your opportunity to traverse the competitive electroceuticals landscape and hear directly from pioneering device developers and innovative start-ups on brand-new data and approaches to explore and expand new frontiers in optimizing treatment for patients in need.

Unmissable Highlights:

Streamline your submission proves with ClearPoint Neuro by delving into the optimal strategies for your development and regulatory process

Reduce patients’ resistance to medical devices with NeuSpera by deep diving into product differentiation and ways to package this to patients and physicians

Grasp novel insights into a wearable bio-ultrasonic therapy with SecondWave Systems and the associated government partnerships and non-dilutive project funding

Optimize funding initiatives with Action Potential Learning by addressing the ways to unite government, industry, and academia towards a shared goal

Leverage clinical studies and RWE with SPR Therapeutics to maximize impact of data and evaluate optimal dosing

Hear From the FDA :


🔉Overview of CDRH & Regulatory Pathways to Provide Novel Neuromodulation & Physical Medicine Devices to Patients

🔉A Comparison of EU & US Regulations to Move Towards Global Harmonization

🔉The Total Product Lifecycle (TPLC) Advisory Program (TAP): Piloting a New

Who Will You Meet:

HW240122 49378 Bioelectric Medicine Development Summit brochure charts

What Your Peers Have to Say:

"Quality speakers. Quality audience. Good opportunities to connect with interesting people" Orthogonal

"Great opportunity to connect with others in this space" Day Zero Diagnostics